Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001829126-26-002162
Filing Date
2026-03-10
Accepted
2026-03-10 16:59:17
Documents
54
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K voyageracq_10k.htm   iXBRL 10-K 984455
2 EXHIBIT 31.1 voyageracq_ex31-1.htm EX-31.1 9302
3 EXHIBIT 31.2 voyageracq_ex31-2.htm EX-31.2 10394
4 EXHIBIT 32.1 voyageracq_ex32-1.htm EX-32.1 7252
  Complete submission text file 0001829126-26-002162.txt   4192416

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vachu-20251231.xsd EX-101.SCH 37356
6 XBRL CALCULATION FILE vachu-20251231_cal.xml EX-101.CAL 32036
7 XBRL DEFINITION FILE vachu-20251231_def.xml EX-101.DEF 172626
8 XBRL LABEL FILE vachu-20251231_lab.xml EX-101.LAB 276162
9 XBRL PRESENTATION FILE vachu-20251231_pre.xml EX-101.PRE 254911
56 EXTRACTED XBRL INSTANCE DOCUMENT voyageracq_10k_htm.xml XML 460818
Mailing Address C/O WINSTON & STRAWN LLP 800 CAPITOL ST., STE 2400 HOUSTON TX 77002
Business Address C/O WINSTON & STRAWN LLP 800 CAPITOL ST., STE 2400 HOUSTON TX 77002 03477204333
Voyager Acquisition Corp./Cayman Islands (Filer) CIK: 0002006815 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-42211 | Film No.: 26740230
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)